Akiram Therapeutics

Akiram Therapeutics is a Swedish biotech company focused on advancing radiotherapeutics to treat solid tumors. The company's unique approach involves combining a radiation component with a proprietary antibody to deliver radioactivity directly to cancer cells while minimizing damage to surrounding healthy tissues. Founded in 2021, Akiram is driven by cutting-edge discoveries made at Uppsala University and boasts a team of experts in radiation sciences, cancer precision medicine, and drug development. The company's mission is to make targeted molecular radiotherapy widely accessible to cancer patients, recognizing the need for personalized treatments in the fight against cancer. Emphasizing the utilization of state-of-the-art radiopharmaceuticals and precision medicine, Akiram aims to create more effective and personalized treatments for individuals battling cancer. Akiram operates within the biotechnology and life sciences industries and is headquartered in Sweden.